SONOMA PHARMACEUTICALS, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price of $116.99 per share for the 6-month period ending 2020-09-30, per its 10-Q filed 2020-11-20.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice · last filed 2020-11-20
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2020-06-30 was $113.38, a 10.79% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2019-06-30 was $127.10, a 1710.54% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2018-06-30 was $7.02, a 97.01% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2017-06-30 was $234.45, a 1216.40% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2016 was $16.25.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2020-09-30 | $116.99 10-Q · filed 2020-11-20 | |||
| 2020-06-30 | $113.38 10-Q/A · filed 2020-11-17 | |||
| 2019-12-31 | $36.61 10-Q · filed 2020-02-14 | |||
| 2019-09-30 | $91.79 10-Q · filed 2019-11-14 | |||
| 2019-06-30 | $127.10 10-Q · filed 2019-08-13 | |||
| 2018-12-31 | $11.91 10-Q · filed 2019-02-14 | |||
| 2018-09-30 | $18.44 10-Q · filed 2018-11-08 | |||
| 2018-06-30 | $7.02 10-Q · filed 2018-08-08 | |||
| 2017-12-31 | $228.22 10-Q · filed 2018-02-14 | |||
| 2017-09-30 | $229.31 10-Q · filed 2017-11-14 | |||
| 2017-06-30 | $234.45 10-Q · filed 2017-08-08 | |||
| 2016-12-31 | $20.15 10-Q · filed 2017-02-17 | |||
| 2016-09-30 | $22.68 10-Q · filed 2016-11-15 | |||
| 2016-06-30 | $17.81 10-Q · filed 2016-08-09 | |||
| 2016-03-31 | $16.25 10-K · filed 2016-06-21 | |||
| 2015-12-31 | $16.48 10-Q · filed 2016-02-16 | |||
| 2015-09-30 | $12.04 10-Q · filed 2015-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |